TP53 and neoplasm: Interestingly, organoids from p53 wild‐type CRC and adjacent nonmalignant tissue revealed that irinotecan plus entinostat significantly eliminated tumor organoids but spared healthy tissue organoids (P < 0.001 for treated tumor organoids to control and to healthy organoids) (Fig. 1G,H).